Dark

GILD
Gilead Sciences Inc
stock NASDAQ

At Close

Sep 11, 2026 3:59:56 PM EDT

143.73USD-0.746%(-1.08)4,202,447

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 11, 2026 9:25:30 AM EDT

145.61USD+0.552%(+0.80)1,462

After-hours

Sep 11, 2026 4:36:30 PM EDT

143.73USD0.000%(0.00)3,708

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

178.28B

Headquarters

Foster City, California, USA

Industry

Drug Manufacturers-General

Next Earnings

Oct 29, 2026 (46d)

Next Dividend

Sep 15, 20260.820

Last Split

Jan 28, 20132for1

AMGN ALXN CELG VRTX ILMN BIIB JNJ LLY MRK ABBV XLV

GILD Stats

Avg. Vol. 10 Day

5,190,156

Avg. Vol. 30 Day

6,042,145

Employees

10,000

Market Cap

178,280,752,186

Shares Out.

1,239,955,155

On/Off Exchange

59%/41%

6 Month Beta

0.36

1 Year Beta

0.33

2 Year Beta

0.38

3 Year Beta

0.34

52 Week Low

108.46

52 Week High

157.29

SMA50

138.09

SMA200

134.73

1 Week

-4.78%

1 Month

+5.82%

3 Month

+14.48%

6 Month

-0.99%

1 Year

+25.52%

2 Year

+72.90%

5 Year

+102.08%

Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

GILD Stock Summary

Gilead Sciences Inc (NASDAQ:GILD) stock price today is $143.73, and today's volume is 4,202,447. GILD is down -0.746% today. The 30 day average volume is 6,042,145. GILD market cap is 178.28B with 1,239,955,155 shares outstanding.

document.getElementById("DzbMzy").onerror = function(){this.style.display='none';}; .dark-mode .ThC2b2{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ThC2b2{ color: #333333; background-color: white; border: 2px solid #333333; }GILDGilead Sciences Incstock NASDAQ

GILD Stock Summary

GILD
Gilead Sciences Inc
stock NASDAQ